From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy
July 31 @ 9:30 am – 11:00 am
Webinar: From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy
Thursday, July 31 | 9:30 a.m.-11:00 a.m. | Free to BioNJ Members
BioNJ and Manatt Health invite you to a high-impact webinar exploring how today’s policy environment is transforming the economics, strategy and logistics of bringing therapies to market. With federal action on drug pricing reform and pharmaceutical supply chain security accelerating, life sciences leaders must adapt to a new set of constraints — and opportunities.
This session will bring together legal, policy and market experts to examine how the policies like the Inflation Reduction Act (IRA), the Most-Favored Nation Executive Order, Budget Reconciliation and the BIOSECURE Act are reshaping drug development timelines, manufacturing strategies and commercialization risk. From pricing pressures and exclusivity reform to reshoring incentives and funding models, we’ll explore how business leaders can position their organizations for resilience and growth.
Key Takeaways: Whether you’re charting policy risks, optimizing your supply chain or planning for long-term growth, this webinar will provide the strategic context and actionable guidance you need to stay ahead.
Topics
Drug Pricing Reform
- How IRA implementation, MFN-style pricing and reconciliation policy are impacting pricing dynamics
- The exclusivity debate and its implications for innovation, especially in rare diseases
- The evolving role of PBMs and pending legislative reforms aimed at transparency and cost control
Supply Chain Resilience
- The risks of global dependencies and policy moves to strengthen U.S.-aligned manufacturing
- Opportunities and challenges in reshoring and rebalancing biopharmaceutical production
- Quality, cost and sourcing trade-offs in a geopolitically complex landscape
- New federal funding pathways and financing models to support domestic production
- Emerging risks from proposals like “Pharma-Ron” and how to engage proactively
Integrated Business Strategy
- Why commercialization, sourcing, manufacturing and logistics planning must be aligned with evolving policy
- How to build resilience across the value chain — from pricing strategy to Patient delivery
Speakers
Nicholas W. Bath, Jr.
Partner
Manatt Health
Michael S. Kolber
Partner
Manatt Health
Melindah Sharma
Managing Director
Manatt Health
Whether you’re a CEO, SVP, Commercial Ops lead, legal advisor or corporate affairs executive, this session is designed to provide the strategic clarity you need to navigate today’s challenges — and tomorrow’s opportunities.
Register today and join us on July 31 for this must-attend webinar on biopharma policy shifts. Registration is FREE to BioNJ Members and $250 for Future BioNJ Members.
